NDC 70511-131

Sincalide

Sincalide

Sincalide is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Maia Pharmaceuticals, Inc.. The primary component is Sincalide.

Product ID70511-131_284554df-38e5-4169-ac60-0b8091ac10cc
NDC70511-131
Product TypeHuman Prescription Drug
Proprietary NameSincalide
Generic NameSincalide
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-11-25
Marketing CategoryNDA /
Application NumberNDA210850
Labeler NameMAIA Pharmaceuticals, Inc.
Substance NameSINCALIDE
Active Ingredient Strength5 ug/5mL
Pharm ClassesCholecystokinin Analog [EPC], Cholecystokinin [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70511-131-84

10 VIAL in 1 PACKAGE (70511-131-84) > 5 mL in 1 VIAL (70511-131-05)
Marketing Start Date2022-11-25
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Sincalide" or generic name "Sincalide"

NDCBrand NameGeneric Name
51808-203SIncalideSincalide
70511-131SincalideSincalide
72266-248SincalideSincalide
0270-0556KINEVACsincalide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.